Epigenetics, drugs of abuse, and the retroviral promoter

Journal of Neuroimmune Pharmacology

Volumn 8, Issue 5, 2013, Pages 1181-1196

  Shirazi, Jasmine ^a   Shah, Sonia ^a   Sagar, Divya ^a   Nonnemacher, Michael R ^a   Wigdahl, Brian ^a   Khan, Zafar K ^a   Jain, Pooja ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Chromatin remodeling; Drug abuse; Epigenetics; HIV 1; LTR

Indexed keywords

ALCOHOL; CANNABIDIOL; CANNABINOID; CANNABINOL; COCAINE; METHAMPHETAMINE; OPIATE; TETRAHYDROCANNABINOL;

ANXIETY DISORDER; ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; COMORBIDITY; DEPRESSION; DISEASE COURSE; DNA METHYLATION; DRUG ABUSE; EPIGENETICS; GENE CONTROL; HEPATITIS C VIRUS; HISTONE MODIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIVER CELL CARCINOMA; MENTAL DISEASE; NUCLEOSOME; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SUBSTANCE ABUSE;

DNA METHYLATION; EPIGENESIS, GENETIC; HIV-1; HUMANS; PROMOTER REGIONS, GENETIC; STREET DRUGS;

EID: 84891372251     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-013-9508-y     Document Type: Article

References (121)

1. Adya N, Giam CZ (1995) Distinct regions in human T-cell lymphotropic virus type I tax mediate interactions with activator protein CREB and basal transcription factors. J Virol 69:1834-1841
2. Alexaki A, Quiterio S, Liu Y, Irish B, Kilareski E, Nonnemacher MR, Wigdahl B (2007) PMA-induced differentiation of a bone marrow progenitor cell line activates HIV-1 LTR-driven transcription. DNA Cell Biol 26:387-394
3. Aliya N, Rahman S, Khan Z, Jain P (2012) Cotranscriptional Chromatin Remodeling by Small RNA Species: an HTLV-1 Perspective. Leuk Res Treatment. doi: 10.1155/2012/984754
4. Amedee AM, Bagby G, Happel KI, Nelson S, Pandrea I (2010) Alcohol's role in HIV transmission and disease progression. Alcohol Res Health 33:203-218
5. Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58:315-348
6. Andria ML, Simon E-J (1999) Localization of promoter elements in the human mu-opioid receptor gene and regulation by DNA methylation. Mol Brain Res 70:54-65
7. Anier K, Malinovskaja K, Aonurm-Helm A, Zharkovsky A, Kalda A (2010) DNA methylation regulates cocaine-induced behavioral sensitization in mice. Neuropsychopharmacology 35:2450-2461
8. Annoni J, Cavassini M, Du Pasquier RA, Hirschel B, Simioni S (2011) HIV-associated neurocognitive disorders: a changing pattern. Future Neurol 6:81
9. Arimondo PB, Egger G, Tost J (2012) Epigenetics. Biochimie 94:2191-2192
10. Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, Schoenbaum EE (2002) Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 17:377-381
11. Bantignies F, Rousset R, Desbois C, Jalinot P (1996) Genetic characterization of transactivation of the human T-cell leukemia virus type 1 promoter: Binding of Tax to Tax-responsive element 1 is mediated by the cyclic AMP-responsive members of the CREB/ATF family of transcription factors. Mol Cell Biol 16:2174-2182
12. Basar K, Sesia T, Groenewegen H, Steinbusch HWM, Visser-Vandewalle V, Ternel Y (2010) Nucleus accumbens and impulsivity. Prog Neurobiol 92:533-557
13. Bateman DN (2012) Opioids. Medicine 40:141-143
14. Baum MK, Rafie C, Lai S, Sales S, Page B, Campa A (2009) Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquir Immune Defic Syndr 50:93-99
15. Bergman Y, Cedar H (2009) Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 10:295
16. Berkhout B, Jeang K (1992) Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J Virol 66:139-149
17. Blazkova J, Trejbalova K, Gondois-Rey F, Halfon P, Philibert P, Guigen A, Verdin E, Olive D, Van Lint C, Hejnar J, Hirsch I (2009) CpG Methylation Control Reactivation of HIV from Latency. PLoS Pathog 5:e1000554
18. Bodor J, Walker W, Flemington E, Spetz AL, Habener JF (1995) Modulation of Tax and PKA-mediated expression of HTLV-I promoter via cAMP response element binding and modulator proteins CREB and CREM. FEBS Lett 377:413-418
19. Buch S, Yao H, Guo M, Mori T, Su T, Wang J (2012) Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction. J Neuroimmune Pharmacol 6:503-515
20. Cabral GA (2006) Drugs of abuse, immune modulation, and AIDS. J Neuroimmune Pharmacol 1:280-295
21. Chao C, Jacobson L, Tashkin D, Martinez-Maza O, Roth MD, Margolick JB, Chmiel JS, Rinaldo C, Zhang Z, Detels R (2008) Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men. Drug Alcohol Depend 94:165-171
22. Chatterjee N, Sinha D, Lemma-Dechassa M, Tan S, Shogren-Knaak MA, Bartholomew B (2011) Histone H3 tail acetylation modulates ATP-dependent remodeling through multiple mechanisms. Nucleic Acids Res 39:8378-8391
23. Chioccarelli T, Cacciola G, Altucci L, Lewis SEM, Simon L, Ricci G, Ledent C, Meccariello R, Fasano S, Pierantoni R, Cobellis G (2010) Cannabinoid receptor 1 influences chromatin remodeling in mouse spermatids by affecting content of transition protein 2 mRNA and histone displacement. Endocrinology 151:5017-5029
24. Clapier CR, Cairns B (2009) The biology of chromatin remodeling complexes. Annu Rev Biochem 78:273-304
25. Deng L, Kashanchi F, Wang D, Wang L, de la Fuente C, Li H (2001) Enhancement of the p300 HAT Activity by HIV-1 Tat on Chromatin DNA. Virology 289:312-326
26. Desplats P, Dumaop W, Smith D, Adame A, Everall I, Letendre S, Ellis R, Cherner M, Grant I, Masliah E (2013) Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology 80:1415-1423
27. Dhillon NK, Williams R, Peng F, Tsai Y, Dhillon S, Nicolay B, Gadgil M, Kumar A, Buch SJ (2007) Cocaine-mediated enhancement of virus replication in macrophages: implications for human immunodeficiency virus-associated dementia. J Neurovirol 13:483-495
28. Drug Enforcement Administration (2011) Drugs of Abuse, 2011 Edition, A DEA Resource Guide. US Dept of Justice. www.justice.gov/dea/drugs-of-abuse-2011. pdf. Accessed 19 Jul 2013
29. du Chene I, Basyuk E, Lin YL, Triboulet R, Knezevich A, Chable-Bessia C, Mettling C, Baillat V, Reynes J, Corbeau P, Bertrand E, Marcello A, Emiliani S, Kiernan R, Benkirane M (2007) Suv39H1 and HP1γ are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency. EMBO 26:424-435
30. Duncan R, Shapshak P, Page JB (2007) Crack cocaine: effect modifier of RNA viral load and CD4 count in HIV infected African American women. Front Biosci 12:488-495
31. Easley R, Van Duyne R, Coley W, Guendel I, Dadgar S, Kehn-Hall K, Kashanchi F (2009) Chromatin dynamics associated with HIV-1 Tat activated transcription. Biochim Biophys Acta 1799:275-285
32. Elgin SC (1990) Chromatin structure and gene activity. Curr Opin Cell Biol 2:437-445
33. ElSohly MA, deWit H, Wachtel SR, Feng S, Murphy TP (2001) Delta9-tetrahydrocannabiviran as a marker for the ingestion of marijuana versus Marinol: reslts of a clinical study. J Anal Toxicol 25:565-571
34. Feng Q, Hassan S, Das T, Huang J, Feng Z (2013) Epigenetic mechanisms in hepatitis C virus-associated hepatocellular carcinoma: a potential new link between stem cells, virology and cancer. Am Med J 4:21-35
35. Gallastegui E, Millan-Zambrano G, Terme J, Chavez S, Jordan A (2011) Chromatin reassembly factors Are involved in transcriptional interference promoting HIV latency. J Virol 85:3187-3202
36. Gan X, Zhang L, Berger O, Stin MF, Way D, Taub DT, Chang SL, Kim KS, House SD, Weinand M, Witte M, Graves MC, Fiala M (1999) Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin Immunol 91:68-76
37. Grimm JW, Lu L, Hayashi T, Hope BT, Su T, Shaham Y (2003) Time-dependent increases in brain-derived Neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci 23:742-747
38. Hammond E, Treisman G (2007) HIV and psychiatric illness. Psychiatr Times 24:57
39. Harrod R, Kuo YL, Tang Y, Yao Y, Vassilev A, Nakatani Y, Giam CZ (2000) p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex. J Biol Chem 275:11852-11857
40. Hauser KF, EL-Hage N, Buch S, Nath A, Tyor WR, Bruce-Keller AJ, Knapp PE (2006) Impact of opiate-HIV-1 interactions on neurotoxic signaling. J Neuroimmune Pharmacol 1:98-105
41. Hwang CK, Song K, Kim CS, Choi HS, Guo X-H, Law P-Y, Wei L-N, Loh HH (2009) Epigenetic programming of μ-opioid receptor gene in mouse brain is regulated by MeCP2 and Brg1 chromatin remodelling factor. J Cell Mol Med 13:3591-3615
42. Imai K, Togami H, Okamoto T (2010) Involvement of Histone H3 Lysine 9 (H3K9) Methyltransferase G9a in the Maintenance of HIV-1 Latency and Its Reactivation by BIX01294. J Biol Chem 285:16538-16545
43. Ishida T, Hamano A, Koiwa T, Watanabe T (2006) 5′ long terminal repeat (LTR)- selective methylation of laently infected HIV-1 provirus that is demethylated by reactivation signals. Retrovirology 3:69
44. Jiang H, Lu H, Schiltz RL, Pise-Masison CA, Ogryzko VV, Nakatani Y, Brady JN (1999) PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner. Mol Cell Biol 19:8136-8145
45. Kashanchi F, Duvall JF, Kwok RP, Lundblad JR, Goodman RH, Brady JN (1998) The coactivator CBP stimulates human T-cell lymphotrophic virus type I Tax transactivation in vitro. J Biol Chem 273:34646-34652
46. Kauder SE, Bosque A, Lindqvist A, Planelles V, Verdin E (2009) Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog 5:e1000495
47. Kauer JA, Malenka R (2007) Synaptic plasticity and addiction. Nat Rev Neurosci 8:844-858
48. Kim W, Kim R, Park G, Park JW, Kim JE (2012) Deficiency of H3K79 Histone Methyltransferase Dot1-like Protein (DOT1L) Inhibits Cell Proliferation. J Biol Chem 287:5588-5599
49. Kiyokawa T, Seiki M, Imagawa K, Shimizu F, Yoshida M (1984) Identification of a protein (p40x) encoded by a unique sequence pX of human T-cell leukemia virus type I. Gann 75:747-751
50. Kovacs JA, Lempicki R, Sidorov IA, Adelsberger JW, Sereti I, Sachau W, Kelly G, Metcalf JA, Davey RT, Falloon J, Polis MA, Tavel J, Stevens R, Lambert L, Hosack DA, Bosche M, Issaq HJ, Fox SD, Leitman S, Baseler MW, Masur H, Di Mascio M, Dimitrov DS, Lane HC (2005) Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. J Clin Invest 115:2139-2148
51. Krebs FC, Hogan TH, Quiterio S, Gartner S, Wigdahl B (2001). Lentiviral LTR-directed Expression, Sequence Variation, and Disease Pathogenesis. In: Kuiken C, Foley B, Hahn B, Marx P, McCutchan F, Mellors JW, Wolinsky S, Korber B (eds) In HIV Sequence Compendium 2001, Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, pp 29-70
52. Kumar A, Choi K, Renthal W, Tsankova NM, Theobald DEH, Truong H, Russo SJ, LaPlant Q, Sasaki TS, Whistler KN, Neve RL, Self DW, Nestler EJ (2005) Chromatin Remodeling is a Key Mechanism Underlying Cocaine-Induced Plasticity in Striatum. Neuron 48:303-314
53. Kwok RP, Laurance ME, Lundblad JR, Goldman PS, Shih H, Connor LM, Marriott SJ, Goodman RH (1996) Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 380:642-646
54. Lefevre F, O'Leary B, Moran M, Mossar M, Yarnold PR, Martin GJ, GLassroth J (1995) Alcohl consumption among HIV-infected patients. J Gen Intern Med 10:458-460
55. Letendre S, Paulino A, Rockenstein E, Adame A, Crews L, Cherner M, Heaton R, Ellis R, Everall IP, Grant I, Masliah E (2007) Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis 196:361-370
56. Levine AA, Guan Z, Barco A, Xu S, Kandel ER, Schwartz JH (2005) CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum. Proc Natl Acad Sci 102:19186-19191
57. Lewinski MK, Bisgrove D, Shinn P, Chen H, Hoffman C, Hannenhalli S, Verdin E, Berry CC, Ecker JR, Bushman FD (2005) Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol 79:6610-6619
58. Li L, Aiamkitsumrit B, Pirrone V, Nonnemacher MR, Wojno A, Passic S, Flaig K, Kilareski E, Blakey B, Ku J, Parikh N, Shah R, Martin-Garcia J, Moldover B, Servance L, Downie D, Lewis S, Jacobson JM, Kolson D, Wigdahl B (2011) Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment. J Neurovirol 17:92-109
59. Lin Y, Flock K, Cook RJ, Hunkele AJ, Loh HH, Ko JL (2008) Effects of trichostatin A on neuronal mu-opioid receptor gene expression. Brain Res 1246:1-10
60. Liu H, Li H, Guo L, Li C, Li M, Jiang W, Liu X, McNutt M, Li G (2009) The mechanism involved in the repression of the μ opioid receptor gene expression in CEM ×174 cells infected by simian immunodeficiency virus. J Leukoc Biol 85:684-691
61. Macian F, Rao A (1999) Reciprocal modulatory interaction between human immunodeficiency virus type 1 Tat and transcription factor NFAT1. Mol Cell Biol 19:3645-3653
62. Mantri CK, Pandhare Dash J, Mantri JV, Dash CCV (2012) Cocaine enhances HIV-1 replication in CD4+ T cells by down-regulating MiR-125b. PLoS ONE 7:e51387
63. Marban C, Suzanne S, Dequiedt F, de Walque S, Redel L, Van Lint C, Aunis D, Rohr O (2007) Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO 26:412-423
64. Marzio G, Giacca M (1999) Chromatin control of HIV-1 gene expression. Genetica 106:125-130
65. Matsuoka M, Jeang KT (2007) Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7:270-280
66. Metzger DS, Navaline H, Woody GE (1998) Drug abuse treatment as AIDS prevention. Public Health Rep 113:97-106
67. Meyaard L, Otto S, Jonker RR, Mijnster MJ, Keet RP, Miedema F (1992) Programmed death of T cells in HIV-1 infection. Science 257:217-219
68. Miller EK (2000) The prefrontal cortex and cognitive control. Nat Rev Neurosci 1:59-65
69. Molina PE, Winsauer P, Zhang P, Walker E, Birke L, Amedee A, Stouwe CV, Troxclair D, McGoey R, Varner K, Byerley L, Lamotte L (2010) Cannabinoid administration attenuates the progression of simian immunodeficiency virus. AIDS Res Hum Retrovir 27:585-592
70. Molina PE, Amedee A, LeCapitaine NJ, Zabaleta J, Mohan M, Winsauer P, Vande Stouwe C (2011) Cannabinoid neuroimmune modulation of SIV disease. J Neuroimmune Pharmacol 6:516-527
71. Nacher M, Adenis A, Hanf M, Adriouch L, Vantilcke V, El Guedj M, Vaz T, Dufour J, Couppie P (2009) Crack cocaine use increases the incidence of AIDS-defining events in French Guiana. AIDS 23:2223-2226
72. Nestler EJ (2008) Transcriptional mechanism of addiction: role of DeltaFosB. Philos Trans R Soc Lond B 363:3245-3255
73. NIDA (2008) Addiction Science: From Molecules to Managed Care. www.drugabuse.gov/publications/addiction-science. Accessed 20 Jul 2013
74. NIDA (2012) Who Is At Risk for HIV Infection and Which Populations are Most Infected? http://www.drugabuse.gov/publications/hivaids/who-risk-hiv- infection-which-populations-are-most-affected. Accessed 29 Sep 2013
75. Nielsen DA, Yuferov V, Hamon S, Jackson C, Ho A, Ott J, Kreek MJ (2009) Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology 34:867-873
76. Nielsen DA, Utrankar A, Reyes JA, Simons DD, Kosten TR (2013) Epigenetics of drug abuse: predisposition or response. Pharmacogenomics 13:1149-1160
77. Noe SN, Nyland S, Ugen K, Friedman H, Klein TW (1998) Cannabinoid receptor agonists enhance syncytia formation in MT-2 cells infectd with cell free HIV-1MN. Adv Exp Med Biol 437:223-229
78. Okada M, Jeang KT (2002) Differential requirements for activation of integrated and transiently transfected human T-cell leukemia virus type 1 long terminal repeat. J Virol 76:12564-12573
79. Pandey SC, Ugale R, Zhang H, Tang L, Prakash A (2008) Brain chromatin remodeling: a novel mechanism of alcoholism. J Neurosci 28:3729-3737
80. Pandhare J, Dash C (2011) A prospective on drug abuse-associated epigenetics and HIV-1 replication. Life Sci 88:995-999
81. Pandya D, Rahman S, Wigdahl B, Khan ZK, Jain P (2007) New insights into the pathogenesis, diagnosis and treatment of human T-cell leukemia virus type 1-induced disease. Futur Virol 2:481-493
82. Paradisi A, Pasquariello N, Barcaroli D, Maccarrone M (2008) Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner. J Biol Chem 283:6005-6012
83. Pearson R, Kim Y, Hokello J, Lassen K, Friedman J, Tyagi M, Karn J (2008) Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. J Virol 82:12291-12303
84. Perrotti LI, Weaver R, Robison B, Renthal W, Maze I, Yazdani S, Elmore RG, Knapp DJ, Selley DE, Martin BR, Sim-Selley L, Bachtell RK, Self DW, Nestler EJ (2008) Distinct patterns of FosB induction in brain by drugs of abuse. Synapse 62:358-369
85. Peterson PK, Gekker G, Hu S, Cabral G, Lokensgard JR (2004) Cannabinoids and morphine differentially affect HIV-1 expression in CD4+ lymphocyte and microglial cell cultures. J Immunol 147:123-126
86. Pfefferbaum A, Rosenbloom M, Sullivan EV (2010) Focus on the brain: HIV infection and alcoholism: comorbidity effects on brain structure and function. Alcohol Res Health 33:247
87. Power C, Boisse L, Rourke S, Gill MJ (2009) NeuroAIDS: an evolving epidemic. Can J Neurol Sci 36:285-295
88. Pulipparachuravil S, Renthal W, Hale CF, Taniguchi M, Guanghua X, Kumar A, Russo SJ, Sikder D, Dewey CM, Davis MM, Greengard P, Naim AC, Nestler EJ, Cowan CW (2008) Cocaine regulates MEF2 to control synaptic and behaviral plasticity. Neuron 59:621-633
89. Purohit V, Rapaka R, Shurtleff D (2011) Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia. Mol Neurobiol 44:102-110
90. Rafati H, Parra M, Hakre S, Moshkin Y, Verdin E, Mahmoudi T (2011) Repressive LTR Nucleosome Positioning by the BAF Complex Is Required for HIV Latency. PLoS Biol 9:e1001206
91. Rahman S, Quann K, Pandya D, Singh S, Khan Z, Jain P (2012) HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter. PLoS 7:13
92. Regan PM, Dave R, Datta PK, Khalili K (2012) Epigenetics of μ-opioid receptors: Intersection with HIV-1 infection of the central nervous system. J Cell Physiol 227:2832-2841
93. Renthal W, Nesler E (2009) Histone acetylation in drug addiction. Semin Cell Dev Biol 20:387-394
94. Research Society on Alcoholism (2011) Impact of Alcoholism and Alcohol Induced Disease on America. www.rsoa.org/2011-04-11RSAWhitePaper.pdf. Accessed 20 Jul 2013
95. Reynolds JL, Mahajan S, Bindukumar B, Sykes D, Schwartz SA, Nair MPN (2006) Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res 1123:226-236
96. Robison AJ, Nestler E (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12:623-637
97. Rock RB, Gekker G, Hu S, Shend WS, Cabral GA, Martin BR, Peterson PK (2007) WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors. J Neuroimmune Pharmacol 2:178-183
98. Roth MD, Tashkin D, Whittaker KM, Choi R, Baldwin GC (2005) Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse. Life Sci 77:1711-1722
99. Russo SJ, Wilkinson M, Mazei-Robison MS, Dietz DM, Maze I, Krishnan V, Renthal W, Graham A, Birnbaum SG, Green TA, Robison B, Lesselyong A, Perrotti LI, Bolanos CA, Kumar A, Clark MS, Neumaier JF, Leve RL, Bhakar AL, Barker PA, Nestler EJ (2009) Nuclear factor kB signaling regulates neuronal morphology and cocaine reward. J Neurosci 29:3529-3537
100. SAMHSA (2012) 2010-2011 National Survey on Drug Use and Health Model-Based Estimates (50 States and the District of Columbia). www.samhsa.gov/data/NSDUH/2k11State/NSDUHsaeTables2011.pdf. Accessed 20 Jul 2013
101. Schroeder FA, Penta K, Matevossian A, Jones SR, Konradi C, Tapper AR, Akbarian S (2008) Drug-induced activation of dopamine D1 receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors. Neuropsychopharmacology 22:2981-2992
102. Scoggin KE, Ulloa A, Nyborg JK (2001) The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation. Mol Cell Biol 21:5520-5530
103. Segal E, Widom J (2009) What controls nucleosome positions? Trends Genet 25:335-343
104. Shah S, Nonnemacher M, Pirrone V, Wigdahl B (2010) Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation. J Neuroimmune Pharmacol 5:278-293
105. Sodroski JG, Rosen CA, Haseltine WA (1984) Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 225:381-385
106. Solum D (2008) Substance abuse. Psychopharmacology Educational Updates. http://www.highbeam.com/doc/1G1-193450168.html. Accessed 21 Jul 2013
107. Strazza M, Pirrone V, Nonnemacher MR (2011) Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res 1399:96-115
108. Takizawa T, Meshorer E (2008) Chromatin and nuclear architecture in the nervous system. Trends Neurosci 31:343-352
109. Treand C, du Chéné I, Bres V, Kiernan R, Benarous R, Benkirane M, Emiliani S (2006) Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter. EMBO 25:1690-1699
110. Tsankova N, Renthal W, Kumar A, Nestler EJ (2007) Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8:355-367
111. Tyagi M, Karn J (2007) CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency. EMBO 26:4985-4995
112. Vale A (2007) Cocaine. Medicine 35:607
113. Vale A (2012) Drugs of abuse (amfetamines, BZP, cannabis, cocaine, GHB, LSD). Poisoning 40:84-87
114. Vignali M, Hassan A, Neely KE, Workman JL (2000) ATP-dependent chromatin-remodeling complexes. Mol Cell Biol 20:1899-1910
115. Wang J, Barke R, Roy S (2007) Transcriptional and epigenetic regulation of interleukin-2 gene in activated T cells by morphine. J Biol Chem 282:7164-7171
116. Wang L, Lv Z, Hu Z, Sheng J, Hui B, Sun J, Ma L (2010a) Chronic cocaine-induced H3 acetylation and trascriptional activation of CaMKIIα in the nucleus accumbens is critical for motivation for drug reinforcement. Neuropsychopharmacology 35:913-928
117. Wang R, Zhang Y, Qing H, Liu M, Yang P (2010b) The extinction of morphine-induced conditioned place preference by histone deacetylase inhibition. Neurosci Lett 483:137-142
118. Wong CCY, Mill J, Fernandes C (2011) Drugs and addiction: an introduction to epigenetics. Addiction 106:480-489
119. Yao H, Kee-Jun K, Duan M, Hayashi T, Guo M, Morgello S, Prat A, Wang J, Su T, Buch S (2012) Cocaine hijacks sigma-1 receptor to initiate induction of ALCAM: Implication for increased monocyte adhesion and migration in the central nervous system. J Neurosci 31:5942-5955
120. Yuan M, Kiertscher S, Cheng Q, Zoumalan R, Tashkin DP, Roth MD (2002) Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J Neuroimmunol 133:124-131
121. Zeng L, Zhou M (2002) Bromodomain: an acetyl-lysine binding domain. FEBS Lett 513:124-128